| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/01/2001 | EP1119334A1 Two chamber cartridge for atomizers |
| 08/01/2001 | EP1119316A1 Buffered resorbable internal fixation devices and methods for making material therefore |
| 08/01/2001 | EP0975350B1 Use of an extract of alchemilla vulgaris |
| 08/01/2001 | EP0957938B1 Composition with base of coconut oil and its use |
| 08/01/2001 | EP0952823B1 Stabilized pharmaceutical compositions and process for the preparation thereof |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0748218B1 Plaster-shaped transdermal system with a tamoxifen derivative |
| 08/01/2001 | EP0742712B1 Bilayered amoxycillin tablets |
| 08/01/2001 | CN2440777Y Dosed medicinal powder adder |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306444A Medical device having anti-infective and contraceptive properties |
| 08/01/2001 | CN1306440A Inhibiting undesirable taste in oral compsns |
| 08/01/2001 | CN1306438A Adjuvant compsn. and methods for its use |
| 08/01/2001 | CN1306421A Matrix-type transdermal patch for steroid homones |
| 08/01/2001 | CN1306420A Methods for treating capules and dry powdered pharmaceutical formulations |
| 08/01/2001 | CN1306413A Foaming compsn. for hair care |
| 08/01/2001 | CN1305843A Exterior-applied Chinese-medicinal plaster for treating bone tuberculosis and its preparing process |
| 08/01/2001 | CN1305833A Medicine for treating postoperative adhesion and its preparing process |
| 08/01/2001 | CN1305809A Chinese medicine tablets |
| 08/01/2001 | CN1305808A Inorganic salt tablets |
| 08/01/2001 | CN1305807A Vitamine tablet |
| 08/01/2001 | CN1305806A Orally applied solid preparation of medicine difficult to dissolve |
| 08/01/2001 | CN1305805A Compsns. contg. ascorbic acid and pectin |
| 08/01/2001 | CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state |
| 08/01/2001 | CN1069099C Dipolymer and trimer of anthraeycline |
| 08/01/2001 | CN1069061C Film for preventing and treating hyperplastic scar and prepn. method thereof |
| 08/01/2001 | CN1069049C Liquid for treating beriberi |
| 08/01/2001 | CN1069046C Liniment for treating bony spur |
| 08/01/2001 | CN1069045C Oral liquid curing AIDS and its preparing method |
| 08/01/2001 | CN1069044C Injection for AIDS and prepn. thereof |
| 08/01/2001 | CN1069038C Effective cream for treatment of contusions and strains |
| 08/01/2001 | CN1069037C Making method or oral capsule for curing difficult and complicated fracture |
| 08/01/2001 | CN1069033C Anti-parasite oral spray contg. evericin and ivermectin for sheep |
| 08/01/2001 | CN1069032C Antiparasitic medicine contg. avermectin/ivermectin for animals |
| 08/01/2001 | CN1069030C Multifunctional collyrium for women |
| 07/31/2001 | US6269157 Bidding for telecommunications traffic with request for service |
| 07/31/2001 | US6268533 Reacting 4-benzyloxy-3-formamidostyrene oxide with an optically pure 4-methoxy-.alpha.-methyl-n-(phenylmethyl)benzeneethanamine followed by reduction to produce formoterol |
| 07/31/2001 | US6268524 Method for preparation of disodium pamidronate |
| 07/31/2001 | US6268516 Cationic amphiphilic lipids for liposomal gene transfer |
| 07/31/2001 | US6268390 Inhibiting stenosis following vascular trauma or disease in a mammalian host. |
| 07/31/2001 | US6268385 Dry blend pharmaceutical formulations |
| 07/31/2001 | US6268368 Antidepressants |
| 07/31/2001 | US6268356 Flocculated suspension of megestrol acetate |
| 07/31/2001 | US6268355 Stable aspirin-containing preparations for external use |
| 07/31/2001 | US6268347 Alleviating neuropathic pain |
| 07/31/2001 | US6268340 In vivo regeneration of oligodendrocytes by bolus injection of NGFβ |
| 07/31/2001 | US6268335 Insoluble insulin compositions |
| 07/31/2001 | US6268053 Blend of macromolecule and polymer |
| 07/31/2001 | US6267990 Preparation comprising initial dose of ace inhibitor optionally including excipient, first delayed-release pellet, in which active ingredient and optional excipient are covered with coating, second coated delayed-release pellet |
| 07/31/2001 | US6267989 Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| 07/31/2001 | US6267988 Composition and method for inducing satiety |
| 07/31/2001 | US6267987 Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake |
| 07/31/2001 | US6267986 Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| 07/31/2001 | US6267985 Clear oil-containing pharmaceutical compositions |
| 07/31/2001 | US6267984 Improved transdermal drug delivery |
| 07/31/2001 | US6267983 Patch comprising substrate sheet comprising mixture of polyvinyl chloride-polyurethane composite and block polymer of butylene, ethylene and styrene, layers of polyurethane adhesive, polyalkylene terephthalate film, primer, adhesive |
| 07/31/2001 | US6267982 Estradiol dissolved in (meth)acrylate copolymer by drying and present in at least three times saturation solubility concentration measured at 95% relative air humidity, enclosed in moisture-tight package with low humidity air |
| 07/31/2001 | US6267981 Method of producing sustained-release preparation |
| 07/31/2001 | US6267980 Dosage forms and uses |
| 07/31/2001 | US6267957 Attaching agents to tissue with transglutaminase and a transglutaminase substrate |
| 07/31/2001 | US6267954 Intraocular transplantation of encapsulated cells |
| 07/31/2001 | US6267808 Mixture of dextrose, film forming, sodium citrate and titanium dioxide |
| 07/31/2001 | US6267310 Process for separating particles of cohesive material according to size |
| 07/31/2001 | CA2241445C Non-aqueous colonic purgative formulations |
| 07/31/2001 | CA2214713C Topical antimicrobial agents |
| 07/31/2001 | CA2068763C Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/31/2001 | CA2041989C Aqueous pharmaceutical formulations of erythropoietin and the use thereof |
| 07/31/2001 | CA2035951C Bilobalide derivatives, their applications and formulations containing them |
| 07/31/2001 | CA1341276C Hyaluronic acid esters and salts |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053444A1 Antimicrobial compositions |
| 07/26/2001 | WO2001053320A2 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 07/26/2001 | WO2001053310A1 Antisense modulation of caspase 3 expression |
| 07/26/2001 | WO2001053266A1 Therapeutic morpholino-substituted compounds |
| 07/26/2001 | WO2001052981A1 Method for modifying the surfaces of fine-porous adsorbents |
| 07/26/2001 | WO2001052918A2 Fluid delivery device with temperature controlled energy source |
| 07/26/2001 | WO2001052897A2 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors |
| 07/26/2001 | WO2001052895A1 Pharmaceutical compositions comprising terbinafine |
| 07/26/2001 | WO2001052894A2 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052888A2 Improved dna vaccines for production-type animals |
| 07/26/2001 | WO2001052876A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | WO2001052866A1 Dextrin containing compositions for prevention of adhesions |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052857A1 Drospirenone for hormone replacement therapy |
| 07/26/2001 | WO2001052848A2 Functional coating of linezolid microcapsules for oral administration |
| 07/26/2001 | WO2001052837A2 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 07/26/2001 | WO2001052833A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | WO2001052826A2 Novel podophyllotoxin compositions |
| 07/26/2001 | WO2001052824A2 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/26/2001 | WO2001052823A2 Compositions to effect the release profile in the transdermal administration of drugs |
| 07/26/2001 | WO2001052822A1 Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications |
| 07/26/2001 | WO2001052821A1 Improved pharmaceutical formulations |
| 07/26/2001 | WO2001052820A1 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these |
| 07/26/2001 | WO2001052819A1 Osmotic device having a preformed passageway that increases in size |
| 07/26/2001 | WO2001052818A1 Dry powder formulations of antihistamine for nasal administration |
| 07/26/2001 | WO2001052817A2 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | WO2001052816A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/26/2001 | WO2001052815A1 Multi-step drug dosage forms |